A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

Clinical trial NCT05959850 · UNKNOWN

Trial details

NCT number: NCT05959850
Sponsor: The Florey Institute of Neuroscience and Mental Health
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2023-06-13
Primary completion: 2024-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.